Skip to content

Prospective follow-up of clinical efficacy of knee distraction as treatment for knee osteoarthritis by use of ‘ArthroSave’s Knee-Reviver’

Prospective follow-up of clinical efficacy of knee distraction as treatment for knee osteoarthritis by use of ‘ArthroSave’s Knee-Reviver’

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25021
Enrollment
75
Registered
2019-08-30
Start date
2017-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

None listed

Sponsors

UMC Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria - adults =65 years of age (at higher ages cost-benefit is becoming less; 15) - BMI 40/100 (conservative treatment resistant)

Exclusion criteria

Exclusion criteria: General: Patients that would not be considered for arthroplasty or osteotomy because of psychosocial condition; or who meet any of the following criteria will be excluded from participation in this study: - Comorbidities that would compromise the efficacy of knee joint distraction (arbitrary defined by orthopaedic surgeons) - History of inflammatory or septic arthritis - Knee mal-alignment of more than 10 degrees - Previous surgical interventions of the index knee < 6 months ago - Absence of any joint space width on both sides (medial and lateral) of X-ray - presence of an endo-prostheses elsewhere

Design outcomes

Primary

MeasureTime frame
WOMAC score and radiographic joint space width evaluated by KIDA software

Secondary

MeasureTime frame
SF36 questionnaire for general wellbeing

Contacts

Public ContactA.C.A. Marijnissen

UMC Utrecht

a.c.a.marijnissen@umcutrecht.nl+31887550459

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)